|
|
Volumn 5, Issue 6, 2004, Pages
|
|
Pharmacogenomics arrives
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE;
GEFITINIB;
IBUPROFEN;
IMATINIB;
NEW DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
TRASTUZUMAB;
AMINO ACID SUBSTITUTION;
BIOTECHNOLOGY;
BREAST CANCER;
CHRONIC MYELOID LEUKEMIA;
CLINICAL STUDY;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
GENE DELETION;
GENE EXPRESSION;
GENE OVEREXPRESSION;
GENE SEQUENCE;
GENOME ANALYSIS;
HIGH THROUGHPUT SCREENING;
HUMAN;
LUNG NON SMALL CELL CANCER;
NOTE;
PHARMACOGENOMICS;
ANIMALS;
DRUG TOXICITY;
HUMANS;
PHARMACOGENETICS;
PHARMACOLOGY, CLINICAL;
|
|
EID: 4043151348
PISSN: 14656906
EISSN: None
Source Type: Journal
DOI: 10.1186/gb-2004-5-6-108 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
